If you're seeing this message, that means
JavaScript has been disabled on your browser
, please
enable JS
to make this app work.
No tags found
Companies
No companies found
Advanced Search
Newsfeed
Alerts
Saved Lists
Sign Up for Free
Login
Update this Profile
Get Updates
661
Followers on Owler
Purdue Pharma
, the inventor of OxyContin, is owned by the Sackler family, and develops and commercializes prescription medicines...
Read more
Overview
Competitors
Acquisitions
Investments
News & Insights
Purdue Pharma
, the inventor of OxyContin, is owned by the Sackler family, and develops and commercializes prescription medicines...
Read more
President & CEO
Craig Landau
CEO Approval Rating
66/100
Weigh In
1991
Stamford
Connecticut
New York Metropolitan Area
Private
Pharmaceuticals & Biotechnology
Pharmaceuticals
2834
2836
NAICS listing
http://www.purduepharma.com
Est. Annual Revenue
$1.0-5.0B
Agree?
Yes
No
Est. Employees
5.0-10K
Agree?
Yes
No
Acquisitions
1
Investments
1
News
Latest News
Feb 21, 2026
Pharmacy Business
Purdue Pharma: Purdue Pharma's Oxycontin fallout clouds Napp's future
Nov 18, 2025
The Washington Times
Purdue Pharma: Here's what's in the opioid settlement against OxyContin maker Purdue, Sackler family
Nov 18, 2025
Fast Company
Purdue Pharma: The OxyContin settlement explained: Where the Sackler family's $7 billion will go
Nov 15, 2025
Seattlepi
Purdue Pharma: Purdue Pharma's deal means money for some victims, end of Purdue company name. Here's what to know
Nov 14, 2025
The New York Times
Purdue Pharma: Judge to Approve Purdue Pharma Bankruptcy, Releasing Billions for Opioid Plaintiffs
Nov 14, 2025
Insurance Business Canada
Purdue Pharma: Massive $10B opioid settlement approved - insurers are off the hook
Nov 12, 2025
Yahoo
Purdue Pharma: Purdue Pharma hearings begin on $7.4 billion opioid settlement plan
Oct 21, 2025
Law 360
Purdue Pharma: Purdue Touts Wide Support For Latest Ch. 11 Plan
Sep 18, 2025
PressReleasePoint
Press Release: Purdue Pharma : Investigational Drug Tinostamustine to be Included in GBM AGILE Clinical Trial for Glioblastoma
Sep 17, 2025
Bloomberg Law
Purdue Pharma: Purdue CEO Gets Nearly $3 Million Bankruptcy Bonus Plan Approved
Follow and Get Alerts
Purdue Pharma Competitors
1
Follow
2
Follow
3
Follow
4
Follow
5
Follow
6
Follow
7
Follow
8
Follow
9
Follow
10
Follow
Unlock 25 + competitors
Trending Companies